| 79.11 Delayed Data As of Aug 22 |  -2.15 / -2.65%Today’s Change | 64.80 Today|||52-Week Range 131.54 | -13.51% Year-to-Date |
| Previous close | 81.26 |
| Today’s open | 81.74 |
| Day’s range | 79.04 - 81.97 |
| Volume | 203,087 |
| Average volume (3 months) | 455,766 |
| Market cap | $3.8B |
| Earnings growth (last year) | -650.19% |
| Earnings growth (this year) | -13.85% |
| Earnings growth (next 5 years) | +7.90% |
| Revenue growth (last year) | +9.35% |
| P/E ratio | NM |
| Price/Sales | 4.01 |
| Price/Book | 2.55 |
| Today’s change | Today’s % change | |
|---|---|---|
| TNDMTandem Diabetes Care... | +4.50 | +7.13% |
| NVRONevro Corp | +0.14 | +0.16% |
| IRTCIrhythm Technologies... | -1.65 | -2.19% |
| BEATBioTelemetry Inc | -0.06 | -0.14% |
| Next reporting date | October 28, 2019 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | -$189.2M |
| Net profit margin | -16.12% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Executive Director Damien McDonald |
Head- Global Operations Marco Dolci |
Corporate headquarters London, Greater London |
